These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. A growth hormone-releasing hormone-producing pancreatic islet cell tumor metastasized to the pituitary is associated with pituitary somatotroph hyperplasia and acromegaly. Sanno N; Teramoto A; Osamura RY; Genka S; Katakami H; Jin L; Lloyd RV; Kovacs K J Clin Endocrinol Metab; 1997 Aug; 82(8):2731-7. PubMed ID: 9253362 [TBL] [Abstract][Full Text] [Related]
64. Effects of growth hormone-releasing hormone (GHRH) on densely granulated somatotroph adenomas and sparsely granulated somatotroph adenomas in vitro: a morphological and functional investigation. Kawakita S; Asa SL; Kovacs K J Endocrinol Invest; 1989; 12(7):443-48. PubMed ID: 2551950 [TBL] [Abstract][Full Text] [Related]
65. Structure-function correlations of growth hormone or/and prolactin-producing pituitary adenomas: an in vitro study with the reverse hemolytic plaque assay. Thodou E; Kontogeorgos G; Kyrodimou E; Salla H; Ramyar L; Vamvassakis E; Piaditis G; Anagnostopoulos N; Tzanis S; Levedis A; Rologis D; Asa SL J Endocrinol Invest; 1999 Oct; 22(9):671-80. PubMed ID: 10595830 [TBL] [Abstract][Full Text] [Related]
66. Pasireotide: successful treatment of a sparsely granulated tumour in a resistant case of acromegaly. Amarawardena WKMG; Liyanarachchi KD; Newell-Price JDC; Ross RJM; Iacovazzo D; Debono M Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28721221 [TBL] [Abstract][Full Text] [Related]
67. The Clinicopathological Spectrum of Acromegaly. Akirov A; Asa SL; Amer L; Shimon I; Ezzat S J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31766255 [TBL] [Abstract][Full Text] [Related]
68. Immune Landscape of Pituitary Tumors Reveals Association Between Macrophages and Gonadotroph Tumor Invasion. Principe M; Chanal M; Ilie MD; Ziverec A; Vasiljevic A; Jouanneau E; Hennino A; Raverot G; Bertolino P J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785693 [TBL] [Abstract][Full Text] [Related]
69. Refractory Pit1 plurihormonal tumours and thyrotroph adenomas. Nf L; Ai M Pituitary; 2023 Apr; 26(2):182-186. PubMed ID: 37117845 [TBL] [Abstract][Full Text] [Related]
70. Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies. Barlier A; Zamora AJ; Grino M; Gunz G; Pellegrini-Bouiller I; Morange-Ramos I; Figarella-Branger D; Dufour H; Jaquet P; Enjalbert A J Neuroendocrinol; 1999 Jul; 11(7):491-502. PubMed ID: 10444306 [TBL] [Abstract][Full Text] [Related]
72. Clinicopathological Features of Growth Hormone-Producing Pituitary Adenomas in 242 Acromegaly Patients: Classification according to Hormone Production and Cytokeratin Distribution. Mori R; Inoshita N; Takahashi-Fujigasaki J; Joki T; Nishioka H; Abe T; Fujii T; Yamada S ISRN Endocrinol; 2013; 2013():723432. PubMed ID: 23401791 [TBL] [Abstract][Full Text] [Related]
73. Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant. Franck SE; Gatto F; van der Lely AJ; Janssen JAMJL; Dallenga AHG; Nagtegaal AP; Hofland LJ; Neggers SJCMM Neuroendocrinology; 2017; 105(1):44-53. PubMed ID: 27455094 [TBL] [Abstract][Full Text] [Related]
74. An Institutional Experience of Tumor Progression to Pituitary Carcinoma in a 15-Year Cohort of 1055 Consecutive Pituitary Neuroendocrine Tumors. Alshaikh OM; Asa SL; Mete O; Ezzat S Endocr Pathol; 2019 Jun; 30(2):118-127. PubMed ID: 30706322 [TBL] [Abstract][Full Text] [Related]
75. Pituitary tumours - a large retrospective single-centre study of over 2300 cases. Experience of a tertiary reference centre. Rak B; Maksymowicz M; Grzywa TM; Sajjad E; Pękul M; Włodarski P; Zieliński G Endokrynol Pol; 2020; 71(2):116-125. PubMed ID: 32154573 [TBL] [Abstract][Full Text] [Related]